Sysnav
  • Home
  • Syde Platform
  • Clinical Research
  • Sysnav HealthCare
  • News & Events
  • Contact
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95 th Centile (SV95C) for Duchenne Muscular Dystrophy.
Learn More
  • Home
  • Syde Platform
  • Clinical Research
  • Sysnav HealthCare
  • News & Events
  • Contact
August 2023

EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy

June 2023

Sysnav Healthcare is participating in the upcoming Rare Disease Endpoint Advancement Pilot Program Workshop.

April 2023

Collaborative Article: “Evolving regulatory perspectives on digital health technologies for medicinal product development”

March 2023

Sysnav Healthcare participation in DiMe’s V3+ project

January 2023

Sysnav Healthcare announces a multi-year collaboration with Roche.

January 2023

SYSNAV HEALTHCARE featured in the January 2023 Magazine of L’Usine Nouvelle.

October 2022

Study Results with SV95C real-world data – Solid Biosciences

Sysnav
  • Syde Platform
  • Clinical Research
  • Sysnav Healthcare
  • Contact

©Sysnav 2023, all rights reserved

Legal mentions

Privacy Policy

General Conditions of Use

Design : Adveris

This site uses cookies to guarantee you the best possible experience.

Accept Decline